ApprovalTrail

Approval · Notice of Compliance 5310 · 1994

ZITHROMAX: Notice of Compliance 5310

Issued May 24, 1994

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
5310
Date
May 24, 1994
Company
Pfizer Canada UlcKirkland, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
New Active Substance (NAS)
Therapeutic class
Antibiotic

Products in this notice

BrandDINStatus today
ZITHROMAX02091291Cancelled Post Market

Medicinal ingredients